Cognitive and field testing of a new set of medication adherence self-report items for HIV care

Ira B Wilson, Floyd J Fowler Jr, Carol A Cosenza, Joanne Michaud, Judy Bentkover, Aadia Rana, Laura Kogelman, William H Rogers, Ira B Wilson, Floyd J Fowler Jr, Carol A Cosenza, Joanne Michaud, Judy Bentkover, Aadia Rana, Laura Kogelman, William H Rogers

Abstract

We conducted four rounds of cognitive testing of self-report items that included 66 sociodemographically diverse participants, then field tested the three best items from the cognitive testing in a clinic waiting room (N = 351) and in an online social networking site for men who have sex with men (N = 6,485). As part of the online survey we conducted a randomized assessment of two versions of the adherence questionnaire-one which asked about adherence to a specific antiretroviral medication, and a second which asked about adherence to their "HIV medicines" as a group. Participants were better able to respond using adjectival and adverbial scales than visual analogue or percent items. The internal consistency reliability of the three item adherence scale was 0.89. Mean scores for the two different versions of the online survey were similar (91.0 vs. 90.2, p < 0.05), suggesting that it is not necessary, in general, to ask about individual medications in an antiretroviral therapy regimen when attempting to describe overall adherence.

Figures

Fig. 1
Fig. 1
Distributions of the three items and the summary scale

References

    1. Haubrich RH, Little SJ, Currier JS, Forthal DN, Kemper CA, Beall GN, et al. The value of patient-reported adherence to antiretroviral therapy in predicting virologic and immunologic response. AIDS. 1999;13:1099–1107. doi: 10.1097/00002030-199906180-00014.
    1. Paterson DL, Swindells S, Mohr J, Brester M, Vergis EN, Squier C, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med. 2000;133(1):21–30. doi: 10.7326/0003-4819-133-1-200007040-00004.
    1. Bangsberg DR, Hecht FM, Clague H, Charlebois ED, Ciccarone D, Chesney M, et al. Provider assessment of adherence to HIV antiretroviral therapy. J Acquir Immune Defic Syndr. 2001;26(5):435–442. doi: 10.1097/00126334-200104150-00005.
    1. Gross R, Bilker WB, Friedman HM, Coyne JC, Strom BL. Provider inaccuracy in assessing adherence and outcomes with newly initiated antiretroviral therapy. AIDS. 2002;16(13):1835–1837. doi: 10.1097/00002030-200209060-00021.
    1. Wendel CS, Mohler MJ, Kroesen K, Ampel NM, Gifford AL, Coons SJ. Barriers to use of electronic adherence monitoring in an HIV clinic. Ann Pharmacother. 2001;35(9):1010–1015. doi: 10.1345/aph.10349.
    1. Bangsberg DR, Hecht FM, Charlebois ED, Zolopa AR, Holodniy M, Sheiner L, et al. Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. AIDS. 2000;14(4):357–366. doi: 10.1097/00002030-200003100-00008.
    1. Kalichman SC, Amaral CM, Cherry C, Flanagan J, Pope H, Eaton L, et al. Monitoring medication adherence by unannounced pill counts conducted by telephone: reliability and criterion-related validity. HIV Clin Trials. 2008;9(5):298–308. doi: 10.1310/hct0905-298.
    1. Bova CA, Fennie KP, Knafl GJ, Dieckhaus KD, Watrous E, Williams AB. Use of electronic monitoring devices to measure antiretroviral adherence: practical considerations. AIDS Behav. 2005;9(1):103–110. doi: 10.1007/s10461-005-1685-0.
    1. Chesney MA. The elusive gold standard: future perspectives for HIV adherence assessment and intervention. JAIDS. 2006;43:S149–S155.
    1. Krousel-Wood M, Islam T, Webber LS, Re RN, Morisky DE, Muntner P. New medication adherence scale versus pharmacy fill rates in seniors with hypertension. Am J Manag Care. 2009;15(1):59–66.
    1. Morisky DE, Ang A, Krousel-Wood M, Ward HJ. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens (Greenwich) 2008;10(5):348–354. doi: 10.1111/j.1751-7176.2008.07572.x.
    1. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24(1):67–74. doi: 10.1097/00005650-198601000-00007.
    1. Morisky DE, Levine DM, Green LW, Shapiro S, Russell RP, Smith CR. Five-year blood pressure control and mortality following health education for hypertensive patients. Am J Public Health. 1983;73(2):153–162. doi: 10.2105/AJPH.73.2.153.
    1. Simoni JM, Kurth AE, Pearson CR, Pantalone DW, Merrill JO, Frick PA. Self-report measures of antiretroviral therapy adherence: a review with recommendations for HIV research and clinical management. AIDS Behav. 2006;10(3):227–245. doi: 10.1007/s10461-006-9078-6.
    1. Wilson IB, Carter AE, Berg KM. Improving the self-report of HIV antiretroviral medication adherence: is the glass half full or half empty? Curr HIV/AIDS Rep. 2009;6(4):177–186. doi: 10.1007/s11904-009-0024-x.
    1. Lu M, Safren SA, Skolnik PR, Rogers WH, Coady W, Hardy H, et al. Optimal recall period and response task for self-reported HIV medication adherence. AIDS Behav. 2008;12(1):86–94. doi: 10.1007/s10461-007-9261-4.
    1. Berg KM, Wilson IB, Li X, Arnsten JH. Comparison of antiretroviral adherence questions. AIDS Behav. 2012;16(2):461–468. doi: 10.1007/s10461-010-9864-z.
    1. Feldman BJ, Fredericksen RJ, Crane PK, Safren SA, Mugavero MJ, Willig JH, et al. Evaluation of the single-item self-rating adherence scale for use in routine clinical care of people living with HIV. AIDS Behav. 2012;17(1):307–318. doi: 10.1007/s10461-012-0326-7.
    1. Wilson IB, Tchetgen E, Spiegelman D. Patterns of adherence with antiretroviral medications: an examination of between-medication differences. J Acquir Immune Defic Syndr. 2001;28(3):259–263. doi: 10.1097/00042560-200111010-00009.
    1. McNabb JJ, Nicolau DP, Stoner JA, Ross J. Patterns of adherence to antiretroviral medications: the value of electronic monitoring. AIDS. 2003;17(12):1763–1767. doi: 10.1097/00002030-200308150-00005.
    1. Gardner EM, Burman WJ, Maravi ME, Davidson AJ. Selective drug taking during combination antiretroviral therapy in an unselected clinic population. J Acquir Immune Defic Syndr Human Retrovirol. 2005;40(3):294–300. doi: 10.1097/01.qai.0000182229.84182.06.
    1. Gardner EM, Sharma S, Peng G, Hullsiek KH, Burman WJ, MacArthur RD, et al. Differential adherence to combination antiretroviral therapy is associated with virological failure with resistance. AIDS. 2008;22(1):75–82. doi: 10.1097/QAD.0b013e3282f366ff.
    1. Deschamps AE. de GS, Vandamme AM, Bobbaers H, Peetermans WE, van WE. Diagnostic value of different adherence measures using electronic monitoring and virologic failure as reference standards. AIDS Patient Care STDS. 2008;22(9):735–743. doi: 10.1089/apc.2007.0229.
    1. Tourangeau R. Cognitive science and survey methods. In: Jabine T, editor. Cognitive aspects of survey methodology: Building a bridge between disciplines. Washington, DC: National Academy Press; 1984. pp. 73–100.
    1. Tourangeau R, Rips LJ, Rasinski K. The psychology of survey response. New York: Cambridge University Press; 2000.
    1. Gaito J. Measurement scales and statistics: resurgence of an old misconception. Psychol Bull. 1982;87:564–7.
    1. Townsend JT, Hu GG, Evans RJ. Modeling feature perception in brief displays with evidence for positive interdependencies. Percept Psychophys. 1984;36(1):35–49.
    1. Ohl ME, Perencevich E, McInnes DK, Kim N, Rimland D, Akgun K, et al. Antiretroviral adherence among rural compared to urban veterans with HIV infection in the United States. AIDS Behav. 2012;17(1):174–180. doi: 10.1007/s10461-012-0325-8.
    1. Beer L, Heffelfinger J, Frazier E, Mattson C, Roter B, Barash E, et al. Use of and adherence to antiretroviral therapy in a Large U.S. Sample of HIV-infected adults in care, 2007–2008. Open AIDS J. 2012;6:213–223. doi: 10.2174/1874613601206010213.
    1. Bauermeister JA, Giguere R, Carballo-Dieguez A, Ventuneac A, Eisenberg A. Perceived risks and protective strategies employed by young men who have sex with men (YMSM) when seeking online sexual partners. J Health Commun. 2010;15(6):679–690. doi: 10.1080/10810730.2010.499597.
    1. Harkness JA, Van de Vijver FJR, Mohler PP. fur Umfragen Z. Cross-cultural survey methods. New York: Wiley; 2003.
    1. Marin G, Marin BVO. Research with hispanic populations. Newbury Park: Sage Publications, Inc.; 1991.

Source: PubMed

Sponsorer og samarbeidspartnere

Medisinsk tilstand

Legemiddelintervensjoner

3
Abonnere